跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,280 条关于
“SK Biopharmaceutical”
全部
3,280
临床试验
46
药物
331
机构
312
资讯
2,591
9个月前
SK Biopharmaceuticals' Cenobamate and Solriamfetol Receive NMPA Approval for China Market
9个月前
SK Biopharmaceuticals Licenses WT-7695 Radiopharmaceutical Targeting CA9 for Solid Tumors
11个月前
SK Biopharmaceuticals and Eurofarma Launch AI-Powered Epilepsy Management Joint Venture
去年
Korean Hospitals Secure Approval for SK Biopharmaceuticals' Cenobamate for Epilepsy Treatment
去年
Cenobamate Shows Strong Efficacy in Northeast Asian Epilepsy Patients in Phase 3 Trial
5个月前
SK Biopharmaceuticals Launches Cenobamate in China, Marking Major Milestone for Epilepsy Treatment
去年
SK Biopharmaceuticals Partners with PhnyX Lab to Deploy AI-Powered Drug Development Platform
2个月前
AI Accelerates Cancer Drug Discovery: SK Telecom and SK Biopharmaceuticals Identify ROR1-Targeting Compounds in Five Months
8天前
FDA Partial Clinical Hold Halts New Enrollment in SK Biopharmaceuticals' Opacalim RISE2 Epilepsy Trial
10个月前
SK Biopharmaceuticals Partners with Interon to Develop First-in-Class Autism Treatment Using Neuroimmune Approach
第 1 页,共 260 页
上一页
下一页